Epidarex Capital
VC / PE · Bethesda · United States
Stages
Investment region
Industries
Profile
Epidarex Capital is a venture capital firm based in Bethesda, Maryland, founded in 2010. The firm is led by a diverse team of early-stage investors focused on building breakthrough life science companies in emerging hubs. With a team of around 10 professionals, Epidarex leverages deep scientific and industry networks to create exceptional value for its portfolio companies. Epidarex Capital invests primarily in life sciences, biotechnology, pharmaceuticals, medical devices, and health technology sectors. The firm targets early-stage investments, particularly in Series A rounds, with a focus on companies based in the United States and the United Kingdom. Epidarex manages several funds, including Epidarex Capital II with $47 million AUM and Epidarex Capital III with $105 million AUM. Notable investments by Epidarex Capital include RapidPulse - stroke aspiration technology, Mironid - therapeutic devices, Leucid Bio - drug discovery, Epsilogen - drug discovery, and Theolytics - drug discovery. These investments highlight the firm's commitment to advancing innovative solutions in the life sciences sector.
Contacts (2)
| Name | Title | Phone | ||
|---|---|---|---|---|
| Co-Founder & Managing Partner | — | — | — | |
| Managing Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.